Back to search

Article

Long-term Metabolic Side Effects of Second-Generation Antipsychotics in Chinese Patients with Schizophrenia: A Within-Subject Approach with modelling of dosage effects

2024-03-04

Abstract excerpt

<h4>Background</h4> Second-generation antipsychotics (SGAs) are commonly used to treat schizophrenia (SCZ), but SGAs may differ in the severity of side effects. Previous observational studies had limitations like failing to account for confounding factors and short follow-up periods. This study compared the long-term metabolic and anthropometric side effects of seven second-generation antipsychotics (SGAs) in a Ch...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
fb53c2f5-96d3-5587-9ca3-f49d1f5989d2
DOI
10.1101/2024.03.04.24303695
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Long-term Metabolic Side Effects of Second-Generation Antipsychotics in Chinese Patients with Schizophrenia: A Within-Subject Approach with modelling of dosage effectsDOI 10.1101/2024.03.04.24303695
Longitudinal impact of different treatment sequences of second-generation antipsychotics on metabolic outcomes: a study using targeted maximum likelihood estimationSemantic proximity
Pharmacogenetic Study of Antipsychotic-Induced Lipid and BMI Changes in Chinese Schizophrenia Patients: A Genome-Wide Association StudySemantic proximity
Pharmacogenetic study of antipsychotic–induced lipid and BMI changes in Chinese schizophrenia patients: A Genome-Wide Association StudySemantic proximity
Interindividual Variability in Olanzapine Steady-State Concentrations in Chinese: Exploring Single Nucleotide Polymorphisms of Metabolic EnzymesSemantic proximity
Pharmacogenetic study of second-generation antipsychotic long-term treatment metabolic side effects (the SLiM Study): rationale, objectives, design and sample description.Semantic proximity
Examining side effect variation in antipsychotic treatment and schizophrenia spectrum disordersSemantic proximity
Effect of Genetic Variants, Gender, and Co-treatment on Olanzapine Plasma Concentration in Chinese patients with schizophreniaSemantic proximity
Genetic variants impacting metabolic outcomes among people on clozapine: a systematic review and meta-analysis.Semantic proximity
Drawbacks of Olanzapine Therapy: An Emphasis on Its Metabolic Effects and DiscontinuationSemantic proximity
Prevalence and factors associated of metabolic syndrome in first- treatment drug-naïve schizophrenia patients: a large-scale cross- sectional studySemantic proximity
HTR2C polymorphisms, olanzapine-induced weight gain and antipsychotic-induced metabolic syndrome in schizophrenia patients: a meta-analysis.Semantic proximity
GENETIC VARIANTS IN ANTIPSYCHOTIC METABOLISM: POLYMORPHISM PROFILES IN KAZAKH COHORT WITH PARANOID SCHIZOPHRENIA.Semantic proximity
Select a neighboring publication to make it the new centre.